Latest Novartis Stories
-- Acromegaly is an endocrine disorder caused by elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels(1) -- Signifor LAR, a next-generation somatostatin
All Federally-Filed Syngenta GMO Corn Lawsuits Accusing the Company of Negligence and Recklessness in Its Handling of GMO Corn Seed Varieties Will Now be Consolidated in U.S.
LONDON, December 12, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Melanoma Drugs - new study showing you trends,
CHICAGO, Dec. 10, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.
Syngenta GMO Corn Seed Lawsuits Allege That U.S.
LONDON, Dec. 4, 2014 /PRNewswire/ -- The North American market for seed treatment in corn/maize is projected to reach US$560.8 million by 2020.
LONDON, Dec. 4, 2014 /PRNewswire/ -- The European market for seed treatment in soybeans is anticipated to register the fastest 2014-2020 CAGR of 6.9% among all crop types.
LONDON, Dec. 4, 2014 /PRNewswire/ -- The Asia-Pacific market for biological seed treatment is projected to reach US$23.6% by 2020 to reflect a robust 9% CAGR between 2014 and 2020.
RESEARCH TRIANGLE PARK, N.C., Dec.